aarogya.com
  • Home
  • Complementary Medicine
    • Ayurveda
    • Homeopathy
    • Naturopathy
    • Acupressure
    • Acupuncture
    • Aromatherapy
    • Batch Flower Remedies
    • Home Remedies
    • Massage
    • Yoga
    • Meditation
    • Reiki
    • Bodywork
    • Medical Palmistry
  • Conditions & Diseases
    • Acute Diarrheal Disease
    • Appendicitis
    • Blindness
    • Brucellosis
    • Chicken Pox
    • Conjunctivitis
    • Dysentery
    • Hookworm
    • Japanese Encephalitis
    • Lymphatic Filariasis
    • Plague
    • Rubella
    • Typhoid Fever
    • Yellow Fever
    • Allergy
    • Arthritis
    • Blood Pressure
    • Computer Health Hazards
    • Chikungunya Fever
    • Dengue
    • Guinea Worm
    • Influenza
    • Leprosy
    • Malaria
    • Poliomyelitis
    • Tetanus
    • Whooping Cough
    • Viral Hepatitis
    • Amebiasis
    • Asthma
    • Bronchitis
    • Diagnostic Tests
    • Cholera
    • Diphtheria
    • Hepatitis
    • Irritable Bowel Syndrome
    • Leptospirosis
    • Measles
    • Rabies
    • Tuberculosis
    • Yaws
  • Family Health
    • Children's Health
    • Diet & Nutrition
    • First Aid
    • Fitness
    • Humor & Trivia
    • Men's Health
    • Preventive Health
    • Senior's Health
    • Senior Citizen Corner
    • Teen’s Health
    • Vets and Pets
    • Women’s Health
  • Health Resources
    • Blood Donation
    • Career Opportunities
    • Daily Health Tips
    • Health Programs
    • Featured Hospitals
    • Medical Education
    • Health Professional's Negligence
    • Medical Tourism
    • Video Eye
    • Rural Health
    • Patients' Rights Forum
  • Insurance
    • Euthanasia
    • Health Insurance
    • Health Insurance Policies
    • Insurance Companies
    • Medical Ethics
    • Medical Jurisprudence
    • Research
    • Telemedicine
    • Compare Health Insurance
  • Sex & Sexuality
    • What is Sex & Sexuality?
    • FAQs
    • Marriage & Pregnancy
    • Sex Education
  • Support Groups
    • Addiction
    • Aids
    • Cancer
    • Epilepsy
    • Swine Flu
    • Blood Search
    • Vivah
    • Health Directory
    • Alzheimer's Disease
    • Medical Support Groups
    • Cardiology
    • Depression
    • Depression Screening Test
    • Diabetes
    • Disability
    • Kidney
    • Obesity
    • Pregnancy
    • Schizophrenia
    • Vitiligo
Aarogya.com
Marathi | Gujarati | Register | Login
  • Home
  • News and Updates
  • Year 2009
  • Scientists Find Cure for Extreme TB Strain

Scientists Find Cure for Extreme TB Strain

  • Print
Details
Hits: 3802
Times of India
3 March 2009
By Kounteya Sinha
New Delhi, India

The world’s most dangerous tuberculosis strain – the extremely drug resistant (XDR) TB – has finally been slain, but only in the lab.

American scientists have found that a combination of two FDA–approved drugs Clavulanate and Meropenem, meant for fighting other bacterial infections like ecoli, completely blocked the growth of 13 strains of XDR TB, isolated in the lab.

According to scientists from Albert Einstein College of Medicine in New York and National Institute of Allergy and Infectious Diseases (NIAID), the drugs worked in tandem – while one brought down the guard of the TB bacteria by inhibiting the enzyme that normally shields it from antibiotics, the other killed it.

Phase II clinical trials on humans are now being planned simultaneously in South Korea and South Africa.

Scientists have reported their breakthrough in the latest issue of the ‘Science’ journal.

Speaking to TOI, Dr John Blanchard, professor of biochemistry at Einstein and senior author of the paper, said that in the lab, scientists successfully killed all XDR TB bacteria in less than two weeks time.

Dr Blanchard said, “The entire discovery happened by chance. We didn’t set out to see whether these two drugs, alone or in combination, fought TB. Now, after three years of lab research, Clavulanate was found to be highly effective in inhibiting the crucial enzyme that shields TB bacteria while Meropenem was highly effective in killing the TB organism completely.” He added, “Normally, it takes two years of continuous therapy to treat drug resistant TB strains. If this combination works in humans, we will be able to completely eliminate the organism within two weeks time.”

Over one–third of the world’s population is infected with TB which claims 1.5 million lives every year globally.

More TB patients are becoming multi–drug resistant (MDR), meaning they don’t respond to the two antibiotics most commonly used against TB.

XDR TB is the most dangerous and is resistant to at least four of the drugs used. Without therapy, death rates in XDR–TB are as high as 100%.

Recently, scientists in India said XDR had been detected in the country and could account for 8% of those suffering from MDR TB. The team examined 3,904 lab samples and found 1,274 were positive for TB. Of these, 32% were multiple drug resistant (MDR–TB), of which 8% were XDR–TB cases.

Mortality rate of XDR–TB patients in the study was as high as 42%. What’s worse, majority of patients with XDR–TB were below 30 years.

"This discovery could be one of the most promising developments in TB research since the discovery of isoniazid," said William Jacobs, professor of microbiology at Einstein.

NIAID researcher Clifton Barry is launching a clinical study of the drug combination in South Korea by the end of 2009 involving approximately 100 TB patients. Additionally, Einstein College of Medicine and the Nelson Mandela School of Medicine in Durban, South Africa are starting a separate trial slated for 2009 that will test the potency of the drug combination in a smaller number of TB patients.

If the results are successful, a trial involving thousands of XDR–TB patients will be conducted.

TB is the single largest killer of AIDS patients in India – over 60% of all AIDS patients contract and ultimately die of TB.

Disclaimer: The news story on this page is the copyright of the cited publication. This has been reproduced here for visitors to review, comment on and discuss. This is in keeping with the principle of ‘Fair dealing’ or ‘Fair use’. Visitors may click on the publication name, in the news story, to visit the original article as it appears on the publication’s website.

0
Introducing Digital Practice for Doctors & Healthcare professionals
Swine Flu
National Award for Outstanding achievement by a Non-Professional - Tushar Sampat
Health Professional's Negligence
Health Professional's Negligence
Records of published articles in the newspapers helps common people about precautions to be taken while seeking the services from health professionals and also helps health professionals to rectify the negligence.
read more…
Specialties
Common Symptoms


Aarogya Network

aarogya.com aims to be India’s leading comprehensive health information portal. The site has sections, which cover almost all the medical specialties and give useful information on various diseases. To enhance its reach, the content is available in Indian languages too. We were the first health website to introduce online support groups. Addiction support and Epilepsy support are examples of some very active and vibrant communities.

» Click here to see all our support groups

Subscribe to Our Newsletter

 Get health related new information.

Pune Aarogya
Digital Media Dedicated to Healthcare of Punekars

Health Tools

  • Health Directory
  • Message Board
  • Health Calculators
  • Depression Screening Test

About Aarogya.com

aarogya.com aims to be India’s leading comprehensive health information portal. The site has sections, which cover almost all the medical specialties

Read more...

Suggestions

This is YOUR site, so if you have suggestions or feedback on how we can improve it for you, please let us know! We do our best to keep up!

Read more...

User Comments

“My name is Paulette Conners and I just had to send you an email thanking you since one of the pages on your site was very helpful!”

  • About Us
  • Company Profile
  • Contact Us
  • Privacy Policy
  • Feedback
  • Disclaimer
  • Sitemap
  • Invite Your Friends

© 2017 www.aarogya.com. All Rights Reserved.